Pfizer (PFE) Reports New Phase 1b Results of Gene Therapy in Ambulatory Boys with DMD Support Advancement into Pivotal Phase 3 Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.06 +0.21 (0.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.85 | 52 Week High | $37.39 | |||
| Open | $30.05 | 52 Week Low | $28.25 | |||
| Day High | $30.21 | P/E | 18.22 | |||
| Day Low | $29.88 | EPS | $1.65 | |||
| Volume | 1,581,694 | |||||
